RT Journal Article
SR Electronic
T1 Time to death and its determinants among neonates admitted to the Neonatal Intensive Care Unit (NICU) of Woldia Comprehensive Specialized Hospital, Amhara region, northeast Ethiopia: A five-year retrospective study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.10.24304055
DO 10.1101/2024.03.10.24304055
A1 Fentaw, Nuhamin
A1 Demis, Asmamaw
YR 2024
UL http://medrxiv.org/content/early/2024/03/13/2024.03.10.24304055.abstract
AB Background Despite an effort to reduce neonatal mortality, Ethiopia is still the leading among the countries with the highest neonatal death. While there have been studies conducted on the overall neonatal mortality rate, there is limited research specifically focusing on the time to death of neonates admitted to the Neonatal Intensive Care Unit (NICU).Objectives To assess the survival time of neonatal death (time to death) and its determinants for neonates admitted to the NICU of Woldia Comprehensive Specialized Hospital (WCSH).Methods A retrospective cohort study was conducted among 604 neonates admitted to the NICU of Woldia comprehensive specialized hospital from January 2018 to December 2022. The data were entered using Epi-Data version 4.6 and analysis was made using STATA version 14 software. To estimate failure probability, the Kaplan-Meier curve and life table estimate were calculated. The log-rank test was used to examine differences in death rates among different categories. The Cox proportional hazards model was employed to identify determinant variables. In the multivariate Cox analysis, variables with a hazard ratio p-value < 0.05 were considered statistically significant at a 95% confidence interval.Results The findings of the study indicate that a total of 604 neonates were included and observed for a cumulative period of 3416 neonate-days. The median time to death among the neonates was 14 days. Out of the reviewed cases, 117 (19.37%) neonates died during the study period. Have no ANC checkup (AHR: 1.68; 95% CI: 1.12-2.52), having bad obstetrics history (AHR: 1.99, 95% CI: 1.28-3.10), having sepsis (AHR: 1.87, 95% CI: 1.23-2.86) and having asphyxia (AHR: 1.64, 95% CI: 1.05-2.58) were increased the hazard of neonatal death.Conclusion The overall neonatal mortality incidence was high. ANC checkup, bad obstetrics history, and specific diagnoses, were found to significantly influence the hazard of neonatal mortality. Increase awareness and education programs for the community regarding the importance of ANC visits. Implement protocols for early identification and management of respiratory distress, sepsis and prenatal asphyxia is critical.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance was obtained specifically from the Institutional review board of Woldia University college of health science. Additionally, authorization to conduct the study and ethical clearance were obtained from the hospital authorities and the ethical committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data will be available based on the situation